PBMWW | Psyence Biomedical Ltd. Warrant Annual & Quarterly

Annual Income Statements

(In USD)

Breakdown	2024	2023	2022
Revenue	-	-	-
Cost of Revenue	-	-	-
Gross Profit	-	-	-
Operating Expenses	46.69 Million	3.23 Million	1.85 Million
Selling, General and Administrative Expenses	1.79 Million	1.62 Million	1.71 Million
Research and Development Expenses	954.59 Thousand	1.6 Million	137.23 Thousand
Other Expenses	879.34 Thousand	-	-
Cost and Expenses	46.69 Million	3.23 Million	1.85 Million
Operating Income	-45.81 Million	-3.23 Million	-1.85 Million
Interest Expense	52.94 Thousand	-	-
Income Tax Expense	1.00	-	-
Earnings before Tax	-51.15 Million	-3.2 Million	-1.85 Million
Net Income	-51.15 Million	-3.2 Million	-1.85 Million
Earnings Per Share Basic	-	-	-
Earnings Per Share Diluted	-	-	-
Weighted Average Shares Outstanding	-	-	-
Weighted Average Shares Outstanding (Diluted)	-	-	-
Gross Margin	-	-	-
EBIT Margin	-	-	-
Profit Margin	-	-	-
EBITDA	-45.81 Million	-3.23 Million	-1.85 Million
Earnings Before Tax Margin	-	-	-

Breakdown	2023 FY	2023 Q2	2022 FY	2021 FY
Revenue	-	-	-	-
Cost of Revenue	-	-	-	-
Gross Profit	-	-	-	-
Operating Expenses	46.69 Million	173.84 Thousand	3.23 Million	1.85 Million
Selling, General and Administrative Expenses	-	198.18 Thousand	-	-
Research and Development Expenses	-	-	-	-
Other Expenses	879.34 Thousand	-24.33 Thousand	-	-
Cost and Expenses	46.69 Million	173.84 Thousand	3.23 Million	1.85 Million
Operating Income	-45.81 Million	-69.65 Thousand	-3.23 Million	-1.85 Million
Interest Expense	52.94 Thousand	-	-	-
Income Tax Expense	932.28 Thousand	8426.40	-	-
Earnings before Tax	-51.15 Million	-305.6 Thousand	-3.2 Million	-1.85 Million
Net Income	-51.15 Million	-314.03 Thousand	-3.2 Million	-1.85 Million
Earnings Per Share Basic	-	-	-	-
Earnings Per Share Diluted	-	-	-	-
Weighted Average Shares Outstanding	-	-	-	-
Weighted Average Shares Outstanding (Diluted)	-	-	-	-
Gross Margin	-	-	-	-
EBIT Margin	-	-	-	-
Profit Margin	-	-	-	-
EBITDA	-	-69.65 Thousand	-	-
Earnings Before Tax Margin	-	-	-	-